SCHOTT Pharma AG & Co. KGaA (FRA: 1SXP)
Germany
· Delayed Price · Currency is EUR | Market Cap | 3.53B |
| Revenue (ttm) | 957.09M |
| Net Income (ttm) | 149.69M |
| Shares Out | n/a |
| EPS (ttm) | 0.99 |
| PE Ratio | 23.57 |
| Forward PE | n/a |
| Dividend | 0.15 (0.64%) |
| Ex-Dividend Date | Feb 5, 2025 |
| Volume | n/a |
| Average Volume | 295 |
| Open | 23.18 |
| Previous Close | 23.62 |
| Day's Range | 23.18 - 23.18 |
| 52-Week Range | 23.18 - 43.20 |
| Beta | n/a |
| RSI | 37.38 |
| Earnings Date | Feb 13, 2025 |
About SCHOTT Pharma AG & Co. KGaA
SCHOTT Pharma AG & Co. KGaA develops, manufactures, and sells drug containment solutions and delivery systems for injectable drugs for pharmaceutical, biotechnology, and life science industries worldwide. The company offers prefillable glass or polymer syringes, glass vials, cartridges, and ampoules. Its syringe products include syriQ, a glass syringe for vaccines; syriQ BioPure, a glass syringe for biologics; syriQ BioPure silicone-free, a prefillable and silicone-free glass syringe for biologics; SCHOTT TOPPAC, a polymer syringe; SCHOTT TOPPA... [Read more]
Financial Performance
In 2024, SCHOTT Pharma AG & Co. KGaA's revenue was 957.09 million, an increase of 6.51% compared to the previous year's 898.60 million. Earnings were 149.69 million, a decrease of -1.42%.
Financial StatementsNews
Schott Pharma carefully observing impact of Trump 2.0 on industry, says CEO
Andreas Reisse, CEO of Schott Pharma, discusses the German pharmaceutical supplier's fourth-quarter earnings.
SCHOTT Pharma Achieves Record Growth and Margins After Strong Year-End
SCHOTT Pharma has marked a milestone year in FY 2024, boasting a 12% revenue surge and a record EBITDA margin of 27.8%. With innovation and strategic alliances, the company is poised for continued suc...
EQS-News: SCHOTT Pharma with strong growth and record margin after solid year-end finish
EQS-News: SCHOTT Pharma AG & Co. KGaA / Key word(s): Annual Report/Annual Results SCHOTT Pharma with strong growth and record margin after solid year-end finish 12.12.2024 / 07:00 CET/CEST The issuer ...
EQS-News: Next-level efficiency and sustainability: SCHOTT Pharma unveils innovative nest design for ready-to-use cartridges
EQS-News: SCHOTT Pharma AG & Co. KGaA / Key word(s): Market Launch Next-level efficiency and sustainability: SCHOTT Pharma unveils innovative nest design for ready-to-use cartridges 04.12.2024 / 11:00...